The Leukaemia Research Group is headed by Professor Øystein Bruserud.
The research has a major focus on the hematological malignancy acute myeloid leukaemia (AML); an aggressive disease that can be cured only by intensive chemotherapy eventually in combination with stem cell transplantation. Our main research areas are:
- Preleukaemic disorders
- Biological and functional characterization of primary human AML cells and their interactions with stromal elements
- Experimental studies of efficiency and toxicity (especially immunotoxicity) of both new targeted therapies and already established therapeutic strategies in human AML.